Trial Profile
Hypertension and Atrial Fibrillation treated by Rivaroxaban for the Morning and Night with synergy with calcium antagonists
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Oct 2020
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Nifedipine
- Indications Thrombosis
- Focus Therapeutic Use
- Acronyms HARMONY
- 04 Dec 2018 Status changed from active, no longer recruiting to completed.
- 14 Nov 2018 Results presented at the 91st Annual Scientific Sessions of the American Heart Association
- 02 Oct 2017 Status changed from recruiting to active, no longer recruiting.